TIDMTHRL
RNS Number : 7651Q
Target Healthcare REIT PLC
01 March 2021
1 March 2021
TARGET HEALTHCARE REIT PLC (the "Company")
RESULTS OF GENERAL MEETING
At a general meeting of the Company's shareholders held at 12
noon today, the resolutions approving the recommended proposals in
respect of the issue of new Ordinary Shares (the "New Shares") on a
non pre-emptive basis pursuant to an initial placing, offer for
subscription, intermediaries offer (together, the "Initial Issue")
and placing programme of New Shares were voted on by way of a poll
and duly passed by shareholders.
In addition, the Board is pleased to confirm that the Board has
today allotted 54,054,054 New Shares in aggregate to subscribers
under the Initial Issue (subject only to Admission on 3 March
2021).
The full text of all the resolutions can be found in the notice
of meeting (contained in the Circular published by the Company on
12 February 2021), copies of which are available for viewing at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism. It is also
available for download from the Company's website:
www.targethealthcarereit.co.uk.
The results of the poll incorporating the proxy votes lodged
before the general meeting, which should be read alongside the
notice of meeting, are noted below and will be available shortly at
www.targethealthcarereit.co.uk .
For Against Withheld
Number of Number Number of
votes % of votes % votes
------------ ----- ---------- ---- -----------
1) Ordinary Resolution 285,808,612 98.3 5,058,226 1.7 412,406
------------ ----- ---------- ---- -----------
2) Special Resolution 275,432,654 98.3 4,898,977 1.7 10,947,612
------------ ----- ---------- ---- -----------
Enquiries:
Target Fund Managers Limited (Investment Manager to the
Company)
+44 1786 845
Kenneth MacKenzie 912
+44 1786 845
Gordon Bland 912
Stifel Nicolaus Europe
Limited
+44 20 7710
Mark Young mark.young@stifel.com 7600
+44 20 7710
Mark Bloomfield mark.bloomfield@stifel.com 7600
+44 20 7710
Rajpal Padam rajpal.padam@stifel.com 7600
FTI Consulting
+44 20 3727
Dido Laurimore TargetHealthcare@fticonsulting.com 1000
Claire Turvey
Richard Gotla
Capitalised terms used and not otherwise defined in this
announcement have the meaning given to them in the Prospectus.
Important Information
The information contained in this announcement is given at the
date of its publication (unless otherwise marked) and is subject to
updating, revision and amendment from time to time.
This announcement does not contain or constitute an offer for
sale or the solicitation of an offer to purchase securities in the
United States. The New Shares have not been and will not be
registered under the US Securities Act of 1933, as amended (the
"Securities Act") or under any securities laws of any state or
other jurisdiction of the United States and may not be offered,
sold, taken up, exercised, resold, renounced, transferred or
delivered, directly or indirectly, within the United States except
pursuant to an applicable exemption from or in a transaction not
subject to the registration requirements of the Securities Act and
in compliance with any applicable securities laws of any state or
other jurisdiction of the United States. There will be no public
offer of the New Shares in the United States.
This announcement is for information purposes only and is not
intended to and does not constitute or form part of any offer or
invitation to purchase or subscribe for, or any solicitation to
purchase or subscribe for, any securities in any jurisdiction. No
offer or invitation to purchase or subscribe for, or any
solicitation to purchase or subscribe for, any securities will be
made in any jurisdiction in which such an offer or solicitation is
unlawful. The information contained in this announcement is not for
release, publication or distribution to persons in the United
States, Canada, Australia, the Republic of South Africa , New
Zealand or Japan, and should not be distributed, forwarded to or
transmitted in or into any jurisdiction, where to do so might
constitute a violation of local securities laws or regulations.
Dickson Minto W.S, which is authorised and regulated by the
Financial Conduct Authority, is acting only for the Company in
connection with the matters described in this announcement and is
not acting for or advising any other person, or treating any other
person as its client, in relation thereto and will not be
responsible for providing the regulatory protection afforded to
clients of Dickson Minto W.S. or advice to any other person in
relation to the matters contained herein.
Stifel Nicolaus Europe Limited, which is authorised and
regulated by the Financial Conduct Authority, is acting only for
the Company in connection with the matters described in this
announcement and is not acting for or advising any other person, or
treating any other person as its client, in relation thereto and
will not be responsible for providing the regulatory protection
afforded to clients of Stifel Nicolaus Europe Limited or advice to
any other person in relation to the matters contained herein.
None of the Company, Target Fund Managers Limited, Dickson Minto
W.S. or Stifel Nicolaus Europe Limited, or any of their respective
affiliates, accepts any responsibility or liability whatsoever for
or makes any representation or warranty, express or implied, as to
this announcement, including the truth, accuracy or completeness of
the information in this announcement (or whether any information
has been omitted from the announcement) or any other information
relating to the Company or associated companies, whether written,
oral or in a visual or electronic form, and howsoever transmitted
or made available or for any loss howsoever arising from any use of
the announcement or its contents or otherwise arising in connection
therewith. The Company, Target Fund Managers Limited, Dickson Minto
W.S. and Stifel Nicolaus Europe Limited, and their respective
affiliates, accordingly disclaim all and any liability whether
arising in tort, contract or otherwise which they might otherwise
have in respect of this announcement or its contents or otherwise
arising in connection therewith.
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS
RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION,
DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED
STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN
THE UNITED KINGDOM, THE REPUBLIC OF IRELAND OR THE NETHERLANDS
(AND, IN THE CASE OF THE NETHERLANDS, ONLY TO PROFESSIONAL
INVESTORS)), CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH
AFRICA, NEW ZEALAND OR ANY OTHER JURISDICTION IN WHICH THE SAME
WOULD BE UNLAWFUL
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ROMSSFFMFEFSEID
(END) Dow Jones Newswires
March 01, 2021 11:52 ET (16:52 GMT)
Target Healthcare Reit (LSE:THRL)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Target Healthcare Reit (LSE:THRL)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
